Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors

The global spread of bacterial resistance to drugs used in therapy requires new potent and safe antimicrobial agents. DNA gyrases represent important targets in drug discovery. Schiff bases, thiazole, and triazole derivatives are considered key scaffolds in medicinal chemistry. Fifteen thiazolyl-tri...

Full description

Bibliographic Details
Main Authors: Cristina Nastasă, Dan C. Vodnar, Ioana Ionuţ, Anca Stana, Daniela Benedec, Radu Tamaian, Ovidiu Oniga, Brînduşa Tiperciuc
Format: Article
Language:English
Published: MDPI AG 2018-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/19/1/222
id doaj-c1051cc5272c449d941870a3ac6599e1
record_format Article
spelling doaj-c1051cc5272c449d941870a3ac6599e12020-11-24T22:36:06ZengMDPI AGInternational Journal of Molecular Sciences1422-00672018-01-0119122210.3390/ijms19010222ijms19010222Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase InhibitorsCristina Nastasă0Dan C. Vodnar1Ioana Ionuţ2Anca Stana3Daniela Benedec4Radu Tamaian5Ovidiu Oniga6Brînduşa Tiperciuc7Department of Pharmaceutical Chemistry, “Iuliu Haţieganu” University of Medicine and Pharmacy, 41 Victor Babeş Street, RO-400012 Cluj-Napoca, RomaniaDepartment of Food Science and Technology, University of Agricultural Sciences and Veterinary Medicine, 3-5 Mănăştur Street, RO-400372 Cluj-Napoca, RomaniaDepartment of Pharmaceutical Chemistry, “Iuliu Haţieganu” University of Medicine and Pharmacy, 41 Victor Babeş Street, RO-400012 Cluj-Napoca, RomaniaDepartment of Pharmaceutical Chemistry, “Iuliu Haţieganu” University of Medicine and Pharmacy, 41 Victor Babeş Street, RO-400012 Cluj-Napoca, RomaniaDepartment of Pharmacognosy, “Iuliu Haţieganu” University of Medicine and Pharmacy, 12 Ion Creangă Street, RO-400010 Cluj-Napoca, RomaniaNational Institute for Research and Development for Cryogenic and Isotopic Technologies, 4th Uzinei Street, RO-240050 Râmnicu Vâlcea, RomaniaDepartment of Pharmaceutical Chemistry, “Iuliu Haţieganu” University of Medicine and Pharmacy, 41 Victor Babeş Street, RO-400012 Cluj-Napoca, RomaniaDepartment of Pharmaceutical Chemistry, “Iuliu Haţieganu” University of Medicine and Pharmacy, 41 Victor Babeş Street, RO-400012 Cluj-Napoca, RomaniaThe global spread of bacterial resistance to drugs used in therapy requires new potent and safe antimicrobial agents. DNA gyrases represent important targets in drug discovery. Schiff bases, thiazole, and triazole derivatives are considered key scaffolds in medicinal chemistry. Fifteen thiazolyl-triazole Schiff bases were evaluated for their antibacterial activity, measuring the growth inhibition zone diameter, the minimum inhibitory concentration (MIC), and the minimum bactericidal concentration (MBC), against Gram-positive (Staphylococcus aureus, Listeria monocytogenes) and Gram-negative (Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa) bacteria. The inhibition of S. aureus and S. typhimurium was modest. Compounds B1, B2, and B9 showed a similar effect as ciprofloxacin, the antimicrobial reference, against L. monocytogenes. B10 displayed a better effect. Derivatives B1, B5–7, B9, and B11–15 expressed MIC values lower than the reference, against L. monocytogenes. B5, B6, and B11–15 strongly inhibited the growth of P. aeruginosa. All compounds were subjected to an in silico screening of the ADMET (absorption, distribution, metabolism, elimination, toxicity) properties. Molecular docking was performed on the gyrA and gyrB from L. monocytogenes. The virtual screening concluded that thiazolyl-triazole Schiff base B8 is the best drug-like candidate, satisfying requirements for both safety and efficacy, being more potent against the bacterial gyrA than ciprofloxacin.http://www.mdpi.com/1422-0067/19/1/222Schiff basethiazoletriazoleantibacterial activityADMETmolecular dockingDNA-gyrase
collection DOAJ
language English
format Article
sources DOAJ
author Cristina Nastasă
Dan C. Vodnar
Ioana Ionuţ
Anca Stana
Daniela Benedec
Radu Tamaian
Ovidiu Oniga
Brînduşa Tiperciuc
spellingShingle Cristina Nastasă
Dan C. Vodnar
Ioana Ionuţ
Anca Stana
Daniela Benedec
Radu Tamaian
Ovidiu Oniga
Brînduşa Tiperciuc
Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors
International Journal of Molecular Sciences
Schiff base
thiazole
triazole
antibacterial activity
ADMET
molecular docking
DNA-gyrase
author_facet Cristina Nastasă
Dan C. Vodnar
Ioana Ionuţ
Anca Stana
Daniela Benedec
Radu Tamaian
Ovidiu Oniga
Brînduşa Tiperciuc
author_sort Cristina Nastasă
title Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors
title_short Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors
title_full Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors
title_fullStr Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors
title_full_unstemmed Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors
title_sort antibacterial evaluation and virtual screening of new thiazolyl-triazole schiff bases as potential dna-gyrase inhibitors
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2018-01-01
description The global spread of bacterial resistance to drugs used in therapy requires new potent and safe antimicrobial agents. DNA gyrases represent important targets in drug discovery. Schiff bases, thiazole, and triazole derivatives are considered key scaffolds in medicinal chemistry. Fifteen thiazolyl-triazole Schiff bases were evaluated for their antibacterial activity, measuring the growth inhibition zone diameter, the minimum inhibitory concentration (MIC), and the minimum bactericidal concentration (MBC), against Gram-positive (Staphylococcus aureus, Listeria monocytogenes) and Gram-negative (Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa) bacteria. The inhibition of S. aureus and S. typhimurium was modest. Compounds B1, B2, and B9 showed a similar effect as ciprofloxacin, the antimicrobial reference, against L. monocytogenes. B10 displayed a better effect. Derivatives B1, B5–7, B9, and B11–15 expressed MIC values lower than the reference, against L. monocytogenes. B5, B6, and B11–15 strongly inhibited the growth of P. aeruginosa. All compounds were subjected to an in silico screening of the ADMET (absorption, distribution, metabolism, elimination, toxicity) properties. Molecular docking was performed on the gyrA and gyrB from L. monocytogenes. The virtual screening concluded that thiazolyl-triazole Schiff base B8 is the best drug-like candidate, satisfying requirements for both safety and efficacy, being more potent against the bacterial gyrA than ciprofloxacin.
topic Schiff base
thiazole
triazole
antibacterial activity
ADMET
molecular docking
DNA-gyrase
url http://www.mdpi.com/1422-0067/19/1/222
work_keys_str_mv AT cristinanastasa antibacterialevaluationandvirtualscreeningofnewthiazolyltriazoleschiffbasesaspotentialdnagyraseinhibitors
AT dancvodnar antibacterialevaluationandvirtualscreeningofnewthiazolyltriazoleschiffbasesaspotentialdnagyraseinhibitors
AT ioanaionut antibacterialevaluationandvirtualscreeningofnewthiazolyltriazoleschiffbasesaspotentialdnagyraseinhibitors
AT ancastana antibacterialevaluationandvirtualscreeningofnewthiazolyltriazoleschiffbasesaspotentialdnagyraseinhibitors
AT danielabenedec antibacterialevaluationandvirtualscreeningofnewthiazolyltriazoleschiffbasesaspotentialdnagyraseinhibitors
AT radutamaian antibacterialevaluationandvirtualscreeningofnewthiazolyltriazoleschiffbasesaspotentialdnagyraseinhibitors
AT ovidiuoniga antibacterialevaluationandvirtualscreeningofnewthiazolyltriazoleschiffbasesaspotentialdnagyraseinhibitors
AT brindusatiperciuc antibacterialevaluationandvirtualscreeningofnewthiazolyltriazoleschiffbasesaspotentialdnagyraseinhibitors
_version_ 1725721313540046848